Cognito Therapeutics raises $105m for Alzheimer’s therapeutic advancement
With a pivotal trial readout for Cognito’s Spectris due later this year, the company anticipates launching the Alzheimer’s disease therapeutic in the US by 2027.
With a pivotal trial readout for Cognito’s Spectris due later this year, the company anticipates launching the Alzheimer’s disease therapeutic in the US by 2027.
The National Healthtech Access Programme aims to improve accessibility to healthtech products across the NHS.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Medical Technology is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Intuitive Surgical expands platforms despite market headwind
The increased importance of safety for wearable devices
What does the EU Data Act mean for businesses?
GE HealthCare launches new ultrasound system for cardiovascular imaging